fdapeptidescompounding
FDA Panel to Review Seven Peptides in July: Notes for Research Users
The FDA will convene an advisory committee in July to consider easing compounding limits on seven peptides; researchers should track the regulatory steps, product-quality markers, and remaining data gaps for research-only use.
April 29, 2026
